secwatch.observer — SEC 8-K summary
======================================

Issuer:     Scholar Rock Holding Corp (SRRK)
CIK:        0001727196
Form:       8-K
Filed at:   2022-07-26T23:59:59+00:00
Accession:  0001104659-22-082822
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Scholar Rock appoints Srinivas Akkaraju to Board of Directors
-------------------------------------------------------------

- Board expanded to nine members; Dr. Akkaraju appointed as Class I director effective July 26, 2022.
- Akkaraju is founder and Managing General Partner at Samsara BioCapital, a recent investor in SRRK.
- He is deemed independent under NASDAQ rules and will receive standard non-employee director compensation.
- Akkaraju serves on boards of Chinook Therapeutics, Intercept Pharmaceuticals, Syros Pharmaceuticals, and others.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1727196/000110465922082822/0001104659-22-082822-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1727196/000110465922082822/tm2221808d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-082822

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer